Literature DB >> 8358937

Two patterns of calcification in primary (physeal) and secondary (epiphyseal) growth cartilage.

R A Brown1, G W Blunn, J R Salisbury, P D Byers.   

Abstract

It is generally stated that the process of cartilage calcification and ossification is the same in the physeal (primary growth center) and epiphyseal (secondary growth center) growth plates. Reexamination of osteophyte growth led to the proposal that these growth plates differ. This proposition was tested by examining rabbit and human material from both sites before and after maceration; both tissue preparations were processed for light microscopy, and the macerated tissues were also studied by scanning electron microscopy (SEM). The physis showed the well-recognized, longitudinal calcified tubal structures in which capillaries make direct contact with and resorb the nonmineralized, transverse septal cartilage. In the epiphysis, the transverse septal cartilage was also mineralized, producing a continuous calcified sheet, perforated only by a limited number of channels and susceptible only to osteoclastic removal. This variation in mineral distribution modifies the way in which the primary spongiosa is formed during growth.

Entities:  

Mesh:

Year:  1993        PMID: 8358937

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  3 in total

1.  Modulation of endochondral development of the distal femoral condyle by mechanical loading.

Authors:  Sona Sundaramurthy; Jeremy J Mao
Journal:  J Orthop Res       Date:  2006-02       Impact factor: 3.494

2.  A functional agarose-hydroxyapatite scaffold for osteochondral interface regeneration.

Authors:  Nora T Khanarian; Nora M Haney; Rachel A Burga; Helen H Lu
Journal:  Biomaterials       Date:  2012-04-22       Impact factor: 12.479

3.  Microvascular features and ossification process in the femoral head of growing rats.

Authors:  S Morini; L Pannarale; A Franchitto; S Donati; E Gaudio
Journal:  J Anat       Date:  1999-08       Impact factor: 2.610

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.